Forway Investment Limited - Net Worth and Insider Trading

Forway Investment Limited Net Worth

The estimated net worth of Forway Investment Limited is at least $4.6 Billion dollars as of 2024-09-25. Forway Investment Limited is the 2101 Beneficial owner of China Shineway Pharmaceutical Group Ltd and owns about 546,802,990 shares of China Shineway Pharmaceutical Group Ltd (HKSE:02877) stock worth over $4.6 Billion. Details can be seen in Forway Investment Limited's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Forway Investment Limited has not made any transactions after 2021-12-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Forway Investment Limited

Forway Investment Limited Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Forway Investment Limited owns 1 companies in total, including China Shineway Pharmaceutical Group Ltd (HKSE:02877) .

Click here to see the complete history of Forway Investment Limited’s form 4 insider trades.

Insider Ownership Summary of Forway Investment Limited

Ticker	Comapny	Transaction Date	Type of Owner
HKSE:02877	China Shineway Pharmaceutical Group Ltd	2021-12-28	2101 Beneficial owner

Forway Investment Limited Latest Holdings Summary

Forway Investment Limited currently owns a total of 1 stock. Forway Investment Limited owns 546,802,990 shares of China Shineway Pharmaceutical Group Ltd (HKSE:02877) as of December 28, 2021, with a value of $4.6 Billion.

Latest Holdings of Forway Investment Limited

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:02877	China Shineway Pharmaceutical Group Ltd	2021-12-28	546,802,990	8.33	4,554,868,907

Holding Weightings of Forway Investment Limited

Forway Investment Limited Form 4 Trading Tracker

According to the SEC Form 4 filings, Forway Investment Limited has made a total of 1 transactions in China Shineway Pharmaceutical Group Ltd (HKSE:02877) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in China Shineway Pharmaceutical Group Ltd is the sale of 0 shares on December 28, 2021, which brought Forway Investment Limited around $0.

Insider Trading History of Forway Investment Limited

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Forway Investment Limited Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Forway Investment Limited Ownership Network

Ownership Network List of Forway Investment Limited

No Data

Ownership Network Relation of Forway Investment Limited

Forway Investment Limited Owned Company Details

What does China Shineway Pharmaceutical Group Ltd do?

Who are the key executives at China Shineway Pharmaceutical Group Ltd?

Forway Investment Limited is the 2101 Beneficial owner of China Shineway Pharmaceutical Group Ltd. Other key executives at China Shineway Pharmaceutical Group Ltd include 2301 Trustee Bh Corporate Services Ltd , 2202 Interest of your spouse Bodnar-horvath Kwai Yung Helen , and 2201 Interest of corporation controlled by you Bodnar-horvath Nicholas Eugene Francis .

China Shineway Pharmaceutical Group Ltd (HKSE:02877) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of China Shineway Pharmaceutical Group Ltd (HKSE:02877) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of China Shineway Pharmaceutical Group Ltd (HKSE:02877) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

China Shineway Pharmaceutical Group Ltd (HKSE:02877)'s detailed insider trading history can be found in Insider Trading Tracker table.

China Shineway Pharmaceutical Group Ltd Insider Transactions

No Available Data

Forway Investment Limited Mailing Address

Above is the net worth, insider trading, and ownership report for Forway Investment Limited. Currently GuruFocus does not have mailing address information for Forway Investment Limited.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.